THE HAGUE – BB Capital Investments has taken an interest in the Travel Health Group (THG). This investment will give THG the opportunity to expand its position as market leader in anti-insect products and travel healthcare innovations.
The purpose of the investment is to double the turnover in the next four years, including the expansion of foreign operations. THG offers, with Tropicare and premium brand Care Plus, a complete healthcare productline for travelers worldwide. Most well known are EU registered DEET anti-insect products and impregnated mosquito nets for the prevention of malaria and other infectious diseases.
“With BB Capital’s participation, we will be able to expand our international growth strategy,” says Arnoud Aalbersberg, CEO of the Travel Health Group. ‘Care Plus products are available throughout Europe within an extensive retail network and in our international webshop. In addition, our most popular products are available as white label. We have 7 unique DEET formulations registered in Europe. Those USPs will make sure we double our current 10 million Euro revenue in the next four years. “
From father to son
Travel Health Group headquarters are located in Almere, The Netherlands. The company was founded in 1988 under the name of Primmed BV by Aalbersberg Sr. as a pharmaceutical wholesaler in travelers vaccines. Under the direction of Arnoud Aalbersberg, the labels Tropicare and Care Plus were introduced in 1992. To make sure travelers are protected is THG’s mission: the combination of information on health risks, education (including shop staff) and the best-performing products are the basis for success. Aalbersberg took over the company from his father in 1999 and from there on focussed on further international expansion. The Travel Health Group has grown to 16 employees with sales outlets in almost 30 countries.
“The Travel Health Group is a company with ambitious goals and proven trackrecord, combined with social involvement and the quality of management, these have been the pillars we based our investment on,” says Susan van Koeveringe of BB Capital Investments. The investment is in line with recent other impact investments made by the The Hague based fund in the past period. BB Capital invests in growing Dutch SMEs in various sectors, including education, healthcare and IT.